Gerrit von Zedlitz's Avatar

Gerrit von Zedlitz

@gerritvzedlitz.bsky.social

Accounting PhD @University of Mannheim and TRR | Interested in #Transparency, #Real Effects and #ESG https://www.bwl.uni-mannheim.de/en/bischof/team/gerrit-von-zedlitz-neukirch-1/

189 Followers  |  487 Following  |  3 Posts  |  Joined: 31.10.2023  |  1.852

Latest posts by gerritvzedlitz.bsky.social on Bluesky

Great opportunity to attend and present at the Doctoral Colloquium and the EAA! I learned a lot, got very useful feedback and met many fascinating people! Many thanks to the organizers :)

31.05.2025 14:01 — 👍 2    🔁 0    💬 0    📌 0
Preview
Forum 2025 - TRR 266 Accounting for Transparency Eine enge Zusammenarbeit von Wissenschaft und Praxis ist entscheidend, um wirtschaftliche Herausforderungen wirksam anzugehen und wirtschaftspolitische Entscheidungen zu verbessern. Wie also können Fo...

Wie können Forschung, Praxis, Regulierung und Politik zusammenarbeiten, um zu einer zielgerichteten und zukunftsorientierten #Politikgestaltung beizutragen? Wir laden sie herzlich ein, am 24. Juni 2025 an der @lmumuenchen.bsky.social mit uns darüber zu diskutieren!

10.04.2025 14:02 — 👍 1    🔁 1    💬 1    📌 0
Post image Post image Post image

What happens to people when researchers encourage them to deactivate Facebook or Instagram for a few weeks in the lead up to an election?

People get modestly* happier/less depressed/less anxious.

"The Facebook effect is driven by people >35, while the Instagram effect is driven by women <25."

21.04.2025 11:47 — 👍 54    🔁 17    💬 5    📌 3
A data visualization presents findings on the effect of measles vaccination on the risk of getting sick or experiencing side effects. The chart features two main sections: "Risk ratio" and "Odds ratio," with each line indicating outcomes after vaccination or placebo. 

The first row highlights that one dose of the vaccine lowers the risk of measles by 95% (or 20 times), while two doses further decrease the risk by 25 times. The subsequent rows detail potential side effects and conditions associated with the vaccine, such as:

- Ulcerative colitis
- Multiple sclerosis
- Inflammatory bowel disease
- ITP (low blood platelets)
- Crohn's disease
- Meningitis
- Acute leukemia
- Type 1 diabetes

Some outcomes, like seizures, show a slight increase in occurrence but are typically brief and non-harmful. The chart indicates that children vaccinated have lower rates of developing pneumonia, while fever and skin rash are noted as side effects that are about twice as likely to occur but tend to resolve quickly.

The visualization includes data sources, emphasizing the comprehensive review behind these findings from the Cochrane Database of Systematic Reviews (2021) and mentions the organization behind the data, Our World in Data.

A data visualization presents findings on the effect of measles vaccination on the risk of getting sick or experiencing side effects. The chart features two main sections: "Risk ratio" and "Odds ratio," with each line indicating outcomes after vaccination or placebo. The first row highlights that one dose of the vaccine lowers the risk of measles by 95% (or 20 times), while two doses further decrease the risk by 25 times. The subsequent rows detail potential side effects and conditions associated with the vaccine, such as: - Ulcerative colitis - Multiple sclerosis - Inflammatory bowel disease - ITP (low blood platelets) - Crohn's disease - Meningitis - Acute leukemia - Type 1 diabetes Some outcomes, like seizures, show a slight increase in occurrence but are typically brief and non-harmful. The chart indicates that children vaccinated have lower rates of developing pneumonia, while fever and skin rash are noted as side effects that are about twice as likely to occur but tend to resolve quickly. The visualization includes data sources, emphasizing the comprehensive review behind these findings from the Cochrane Database of Systematic Reviews (2021) and mentions the organization behind the data, Our World in Data.

How effective and safe are measles vaccines?

In a new chart & article, I summarize the findings of a Cochrane meta-analysis on measles vaccination. 🧵

21.04.2025 12:01 — 👍 109    🔁 39    💬 2    📌 3

Great data!

14.02.2025 09:53 — 👍 0    🔁 0    💬 0    📌 0
Preview
CSRD 2.0: getting the right data from the right companies Katharina Hombach, Maximilian Müller and Thorsten Sellhorn are co-founders of the Sustainability Reporting Navigator Evidence-backed advice for the European Commission as it gears up to simplify the E...

The debate on CSRD reform regarding the upcoming „omnibus“ package is in full swing. The latest OpEd in @sustainableviews.bsky.social by TRR 266 members provides evidence-backed insights for the European Commission.

Check it out: www.sustainableviews.com/csrd-2-0-get...

13.02.2025 14:21 — 👍 3    🔁 1    💬 0    📌 0
Preview
Unpacking Transparency: How it shapes organizations and markets How does transparency shape organizations and markets? Read more about transparency research in tax & disclosure regulations and managament controls.

Transparency is crucial in today's organizations and markets, influencing decision-making, market efficiency, and information symmetry. The SBUR just published the #trr266 study "Accounting for Transparency: a Framework and Three Applications in Tax, Managerial, and Financial Accounting“.

20.01.2025 12:05 — 👍 4    🔁 1    💬 1    📌 0
Post image

On Dec 17th 2024, the #TRR266 / TAF Brown Bag Seminar brought researchers together at @unipaderborn.bsky.social .

TRR 266-member Dr. Christian Friedrich (Uni Mannheim) presented "When Disclosing Effective Compliance Backfires", sparking great discussions on compliance disclosures.

07.01.2025 12:45 — 👍 3    🔁 1    💬 1    📌 0
Post image

Last week I had the great opportunity to present our project on climate stress tests (with Jannis Bischof, Vincent Giese and Luzi Hail) as part of the Brown Bag Series at the TAF department of the University of #Paderborn.
@trr266.bsky.social

25.11.2024 19:57 — 👍 3    🔁 1    💬 0    📌 0

📢 Don't miss this opportunity to join the first Open TRR 266 Conference at LMU Munich on 23 June 2025. This event brings together researchers from within and outside the #trr266 to discuss current research in the areas of #accounting, #taxation, and #transparency.

18.11.2024 11:21 — 👍 2    🔁 2    💬 1    📌 0

I created this starter pack for accounting researchers on Bluesky. If you’re interested in following people doing interesting research in financial accounting, capital markets, management accounting, auditing, et cetera, start here!

go.bsky.app/FqBLFAZ

07.11.2024 07:06 — 👍 23    🔁 12    💬 9    📌 1
TRR 266 Forum 2023: "Grüne Transparenz oder Datendschungel?"
Für Unternehmen wird es immer wichtiger, den eigenen Erfolg auch in den Bereichen Umwelt, Soziales und Unternehmensführung (ESG) zuverlässig zu bewerten. Ins... TRR 266 Forum 2023: "Grüne Transparenz oder Datendschungel?"

Rückblick zum TRR 266 Forum „Grüne Transparenz oder Datendschungel“ an der Uni Mannheim: Wir haben intensiv mit Vertreter*innen aus Praxis, Politik, Regulierung & Wissenschaft über ESG-Herausforderungen diskutiert. Einige Erkenntnisse und Highlights: www.youtube.com/watch?v=1Bx5...

17.11.2023 13:59 — 👍 6    🔁 1    💬 1    📌 0
Post image

Now available: The 2022 Global MNC Tax Complexity Survey data from TRR 266 researchers Simon Harst, Felix Siegel, Deborah Schanz and Caren Sureth-Sloane reveal a sustained high level of tax complexity. Again, their data illustrate transfer pricing rules as the most complex tax regulation.

21.11.2023 10:09 — 👍 3    🔁 2    💬 1    📌 0
Preview
Society for Financial Studies on LinkedIn: The Review of Financial Studies The December issue of RFS has published! The Editor’s Choice paper is: “More Risk, More Information: How Passive Ownership Can Improve Informational…

Our paper “Firm-Level Exposure to Epidemic Diseases: COVID-19, SARS, and H1N1” published in the December issue of RFS www.linkedin.com/posts/societ... Many thanks to the editorial team, in particular Ralph Koijen

23.11.2023 06:19 — 👍 1    🔁 1    💬 0    📌 0

@gerritvzedlitz is following 20 prominent accounts